This study also demonstrates the capabilities of MicroED for structure-based drug design.

These results provide a mechanistic foundation for future aGPCR-targeted drug design.

It is likely to prove useful for protein and drug design.

More generally, these findings provide a basis for a novel drug design platform.

XtalPi uses AI, cloud computing and quantum physics to improve drug design processes.

I'm a believer in this what you call rational drug design.

Thanks to improvements in drug design, research techniques and experimental methods, alternatives do exist.

These results bring new insights for studies with venom compounds, PIs, and drug design.

Using a structure-based drug design approach, a series of 5-substituted triclosan derivatives was developed.

A recent trend toward more rational drug design was observed.

These findings provide the basis for new targets for drug design or cancer therapy.

Our findings thus far provide evidence in support of this new approach to drug design.

Accordingly, computational prediction of protein-carbohydrate binding free energies is of enormous interest for drug design.

The discovery of these agents has not always been the result of rational drug design.

Its essential character in bacterial cells makes it an attractive target for antibacterial drug design.

Conclusion: A novel perspective is presented, suggesting new molecular properties to be included in drug design.